Skip to content

Trimas TRS Deferred Tax Assets, Research And Experimentation

Deferred Tax Assets, Research And Experimentation at other companies

DJT
Trump Media & Technology GroupDJT
$2.68M-14.6%
Quantum Computing Inc. logo
Quantum Computing Inc.QUBT
$6.24M+144%
Nuvation Bio logo
Nuvation BioNUVB
$78.79M-19.0%
PepsiCo logo
PepsiCoPEP
$134M-47.7%
HRO
HarrowHROW
$78K-86.5%
Minerals Technologies logo
Minerals TechnologiesMTX
$12.6M+14.5%

Other financials

Income statement

See full
Revenue$168.3M+10.4%
Gross profit$36.9M+12.3%
Operating income$6.9M-3.6%
Net income$800.8M+6,348%
EPS (diluted)$21.40+7,033%

Balance sheet

See full
Cash & equivalents$1.3B+3,904%
Total debt$439.9M-9.2%
Total equity$1.4B+111%
Total assets$2.3B+64.8%

Cash flow

See full
Operating cash flow-$19.4M-311%
CapEx$5.2M-59.7%
Free cash flow-$24.6M-556%

Valuation

See full
Market cap$1.56B+41.9%

Profitability

See full
Gross margin-0.1%-2.1pp
Operating margin8%-1.0pp
Net margin137.3%+132pp
FCF margin7.3%+3.1pp

Returns & leverage

See full
Return on equity85.1%+80.4pp
Debt / equity0.3×-0.4×
Current ratio4.9×+2.0×

Where this comes from

Reported directly by Trimas in its filing.

Tagged under the XBRL concept trs:DeferredTaxAssetsResearchAndExperimentation.

The official record: Trimas’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trimas's deferred tax assets, research and experimentation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trimas's deferred tax assets, research and experimentation?
Trimas (TRS) reported deferred tax assets, research and experimentation of $0 in Q4 2025.
How has Trimas's deferred tax assets, research and experimentation changed year-over-year?
Trimas's deferred tax assets, research and experimentation decreased by 100.0% year-over-year, from $5M to $0.
What does deferred tax assets, research and experimentation mean?
This represents the deferred tax asset arising from the capitalization and amortization of research and experimentation costs for tax purposes. It indicates the future tax savings the company expects to realize due to its investment in innovation and product development.